Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog) After Ingestion of a Standardized Meal

Trial Profile

Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog) After Ingestion of a Standardized Meal

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Mar 2017

At a glance

  • Drugs Insulin lispro (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Adocia
  • Most Recent Events

    • 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 16 Sep 2016 Results assessing ultra-rapid pharmacokinetic characteristics of BioChaperone Lispro, presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.
    • 06 Jun 2016 Results will be presented at the American Diabetes Association 76th Scientific Sessions 2016, according to an Adocia media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top